2010

Jul. 15th Start of Phase III Clinical Trial for MRX-7EAT
Apr. 9thThe LOI with AnGes MG Inc. on the Transdermal Formulation containing NF-B Decoy Oligonucleotide

2009

Oct. 1stEstablishmenet of a new joint venture campany
Aug. 20thgDevelopment of a new cancer pain relief patch to apply the ionic liquid technologyh was passed by NEDO (New Energy and Industrial Technology Development Organization) as its innovation advancement project.
May. 26thEtodolac Patch (MRX-7EAT) became available for Phase I clinical trial in U.S.

2008

Dec. 2nd.License Agreement of Transdermal Absorption Technology for Macromolecules
--- Grant of the exclusive license about the transdermal formulation containing NF-B decoy oligo in North America and EU ---

2007

Aug. 2ndOur consortium R&D project was adopted by Ministry of Economy, Trade and Industry as " Consortium R&D projects for regional revitalization in 2007"
Oct. 10thLaunch Medcaine Oral Jelly 2%

2005

Aug. 22ndLaunch Iodocoat Ointment 0.9%